Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 824,725				$ 0	$ 0	$ 1,497,373	$ (725,648)	$ (705)	$ 53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023					94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					7,358,000	(7,358,000)
Issuance of common stock related to vested exercised stock options (in shares)						2,060,000
Issuance of common stock related to vested exercised stock options	17,933						17,933
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(13,000)
Issuance of common stock related to RSUs vested (in shares)					1,038,000
Charitable donation of common stock (in shares)			133,389	134,000
Charitable donation of common stock	5,350		$ 5,300				5,350
Vesting of early exercised stock options	809						809
Stock-based compensation expense	78,698						81,359			(2,661)
Change in noncontrolling interest ownership							(503)			503
Other comprehensive income (loss)	81								2,487	(2,406)
Net income (loss)	(104,107)							(102,549)		(1,558)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240				$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	815,601				$ 0	$ 0	1,542,603	(778,117)	1,003	50,112
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2023					96,240,000	56,453,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					6,213,000	(6,213,000)
Issuance of common stock related to vested exercised stock options (in shares)						940,000
Issuance of common stock related to vested exercised stock options	10,320						10,320
Issuance of common stock under employee stock purchase plan (in shares)					247,000
Issuance of common stock under employee stock purchase plan	7,751						7,751
Repurchases, net of early exercised stock options (in shares)						(2,000)
Issuance of common stock related to RSUs vested (in shares)					679,000
Charitable donation of common stock (in shares)			52,647	53,000
Charitable donation of common stock	2,675		$ 2,700				2,675
Vesting of early exercised stock options	292						292
Stock-based compensation expense	46,368						46,555			(187)
Change in noncontrolling interest ownership							(124)			124
Other comprehensive income (loss)	(559)								779	(1,338)
Net income (loss)	(51,208)							(50,080)		(1,128)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2023					103,432,000	51,178,000
Stockholders' Equity, ending balance at Jul. 31, 2023	831,240				$ 0	$ 0	1,610,072	(828,197)	1,782	47,583
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	831,240				0	0	1,610,072	(828,197)	1,782	47,583
Stockholders' Equity, beginning balance	$ 617,934	[1]			$ 0	$ 0	1,718,661	(1,149,822)	2,335	46,760
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2024					114,670,000	42,887,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					19,855,000	(19,855,000)
Issuance of common stock related to vested exercised stock options (in shares)	931,000					931,000
Issuance of common stock related to vested exercised stock options	$ 10,074						10,074
Issuance of common stock under employee stock purchase plan (in shares)					252,000
Issuance of common stock under employee stock purchase plan	7,932						7,932
Issuance of common stock related to RSUs vested (in shares)					1,565,000
Charitable donation of common stock (in shares)			120,241		120,000
Charitable donation of common stock	5,914		$ 5,900				5,914
Vesting of early exercised stock options	189						189
Stock-based compensation expense	91,221						91,425			(204)
Change in noncontrolling interest ownership							(409)			409
Other comprehensive income (loss)	(2,647)								(1,765)	(882)
Net income (loss)	(42,613)							(41,695)		(918)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024					136,462,000	23,963,000
Stockholders' Equity, ending balance at Jul. 31, 2024	688,004	[1]			$ 0	$ 0	1,833,786	(1,191,517)	570	45,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	614,358				$ 0	$ 0	1,768,947	(1,204,466)	3,360	46,517
Stockholders' Equity, beginning balance (in shares) at Apr. 30, 2024					132,670,000	26,212,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)					2,619,000	(2,619,000)
Issuance of common stock related to vested exercised stock options (in shares)						370,000
Issuance of common stock related to vested exercised stock options	4,981						4,981
Issuance of common stock under employee stock purchase plan (in shares)					252,000
Issuance of common stock under employee stock purchase plan	7,932						7,932
Issuance of common stock related to RSUs vested (in shares)					854,000
Charitable donation of common stock (in shares)			67,015	67,000
Charitable donation of common stock	2,957		$ 2,900				2,957
Vesting of early exercised stock options	91						91
Stock-based compensation expense	48,969						48,877			92
Change in noncontrolling interest ownership							1			(1)
Other comprehensive income (loss)	(3,558)								(2,790)	(768)
Net income (loss)	12,274							12,949		(675)
Stockholders' Equity, ending balance (in shares) at Jul. 31, 2024					136,462,000	23,963,000
Stockholders' Equity, ending balance at Jul. 31, 2024	688,004	[1]			$ 0	$ 0	1,833,786	(1,191,517)	570	45,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 688,004	[1]			$ 0	$ 0	$ 1,833,786	$ (1,191,517)	$ 570	$ 45,165

[1] (1) As of July 31, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $45.0 million and $47.6 million, respectively, and liabilities of $6.5 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.